Line Holten Reimer

Rehfeld Medical ApS develops and distributes software and information technology solutions for clinical processes. It provides platform, such as SCAUT, to support treatment of remotely monitored heart patients. The company was founded by Jonas Jermiin Ravn Moll in 2014 and is headquartered in Copenhagen, Denmark.

SEED Capital Management I/S is an Independent Venture Capital firm founded in 2004. The company is headquartered in Copenhagen, Denmark.

MedicoSelskabet September 2014 ApS is a holding company that develops medical devices for cardiovascular sensing. Its scheme is based on a concept that does not interfere with the state of the patient. It improves the method of measuring hypertension and suitable for ambulatory continuous measurements. Its also involves in the repair of communication equipment. The company was founded by Ole Kjerulf Jensen and Lars Lading on June 14, 2002 and is headquartered in Hellerup, Denmark.

Dep-Xplora ApS provides drugs in the development of depots for joint injections. Its non-steroidal anti-inflammatory drugs are widely used as rescue medicine to relieve moderate to severe postoperative pain after minor joint surgery and to alleviate inflammatory pain associated with various arthritis conditions. The firms prodrug approach taken enables establishment of drug concentration to manage pain and inflammation at the site of action and at the same time minimizes the risk of systemic adverse events. The company was founded by Jens Hansen and Claus Selch Larsen in 2012 and is headquartered in Lejre, Denmark.

Aros Pharma ApS is a holding company that develops medicine targeting unmet needs within pain relief, infectious disease, inflammation, respiratory diseases, and immuno-suppressed patients. It is a biotech company that focuses on clinical development of a novel therapy for the treatment of gastrointestinal pain. The firm is developing a new pain relief therapy based on a small molecule (PPC-5650) that is a specific inhibitor of the ASIC 1a receptor (Acid Sensing Ion Channel subtype 1a). Its therapy is currently being tested in two phase I trials targeting pain in patients who suffer from Irritable Bowel Syndrome (IBS) or non-erosive Gastroesophageal Reflux Disease (NERD). The company was founded in 2009 and is headquartered in Copenhagen, Denmark.

Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark.

TagAway Devices ApS operates as a medical research and development company. The firm develops self-care devices for the removal of skin tags without bleeding, scarring, pain or infection. The company was founded by Staffan Sundström and is headquartered in Hørsholm, Denmark.

Oracain ApS develops oral pain medications based on known active compounds. It is developing a novel pharmaceutical product for pain associated with oral mucositis and other complex conditions. The company was founded by Ove Andersen in 2011 and is headquartered in Lyngby, Denmark.

Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.